Nebius Earnings Preview: Growth Now, Rubin Expansion Ahead

Group 1 - Nebius has been active in late December and January, announcing Nebius AI Cloud 3.1 [1] - The company is focused on biotechnology, particularly in identifying innovative companies with unique mechanisms of action and first-in-class therapies [1] - The approach emphasizes evaluating the science behind drug candidates, competitive landscape, clinical trial design, and market opportunities while balancing financial fundamentals [1]